Exicure (XCUR) Goodwill & Intangibles (2025 - 2026)
Exicure (XCUR) reported Goodwill & Intangibles of $8.2 million for Q1 2026, up 14.87% on a YoY basis from $7.1 million in Q1 2025, and little changed quarter-over-quarter from $8.2 million in Q4 2025.
Exicure (XCUR) Goodwill & Intangibles (2025 - 2026) Analysis & Trends
Exicure has reported Goodwill & Intangibles for 2 years, with the latest figure at $8.2 million in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles rose 14.87% year-over-year to $8.2 million; the trailing twelve-month figure through Mar 2026 stood at $8.2 million (up 14.87% YoY), and the FY2025 full-year result was $8.2 million, changed N/A from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $8.2 million, roughly flat from $8.2 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $8.2 million in Q4 2025, with the low at $7.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.18 Mn |
| Dec 31, 2025 | 8.18 Mn |
| Sep 30, 2025 | 7.12 Mn |
| Jun 30, 2025 | 7.12 Mn |
| Mar 31, 2025 | 7.12 Mn |